Supplementary Tables S16-S20 from A Four-gene Decision Tree Signature Classification of Triple-negative Breast Cancer: Implications for Targeted Therapeutics

Supplementary Table S16: Results from the gene set enrichment analysis of 28 different immune signatures across the METABRIC-set 15 (MC subtypes) classification. Supplementary Table S17: Table representing the copy number status of the five genes part of the MAPK inactivation score across the METABRIC-set 15 (MC subtypes) classification. Supplementary Table S18: Output of the multivariable logistic regression analysis for the MC6 and the BL1 subtype in Sanofi Phase II. Supplementary Table S19: Output of the multivariable logistic regression analysis for the MC6 and the BL1 subtype in Sanofi Phase III. Supplementary Table S20: Results from the drug screen performed between MC6 and non-MC6 TNBC cell lines.